Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1317 18 |
Ultima descărcare din IBN: 2023-06-25 10:33 |
SM ISO690:2012 NACU, Anatolie, КЭРЭУШУ, Генадий. Риспаксол (Рисперидон) – клинико-терапевтическая эффективность
. In: Curierul Medical, 2009, nr. 2 (308), pp. 11-13. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | |||||
Numărul 2 (308) / 2009 / ISSN 1875-0666 | |||||
|
|||||
Pag. 11-13 | |||||
|
|||||
Descarcă PDF | |||||
Rezumat | |||||
Rispaxol (Risperidone) – Clinical and Therapeutic Effectiveness
The trial represents the assessment of the efficiency of Rispaxol (Risperidone) in treatment of 40 patients hospitalized in the Psychiatric Clinical Hospital of
the Ministry of Healthcare of the Republic of Moldova in 2008, which were suffering the Paranoid Schizophrenia, depressive-paranoid syndrome, and Recurrent
Depressive Disorder, the current severe episode, with psychotic symptoms, resistant to treatment. The observations of the main parameters and scales readings
have shown that Rispaxol (risperidone), taken in an average daily dose of 4 mg, due to its efficiency and tolerability, is the medication of choice in the case of such
disorders. The presented data open the broad opportunities with regard to using of Rispaxol for in-patient and subsequent out-patient care practice.
|
|||||
Cuvinte-cheie Rispaxol, clinical and therapeutic effectiveness, Risperidone |
|||||
|